Partners

Partners

I-GENE Consortium is composed of 5 partners (2 from Accademia and 3 from Industry), recognized for excellence in the field of gene therapy, nanomedicine, photonics and material science.

UNIPI

UNIVERSITY OF PISA (IT)

PROCHIMIA

PROCHIMIA SURFACES SP.Z.O.O. (PL) 

IIT

ISTITUTO ITALIANO DI TECNOLOGIA (IT)/ Plasmon Nanotechnologies line

M2

M-SQAURED LASERS LIMITED (UK)

LIONIX

LIONIX INTERNATIONAL BV (NL)
unipi

UNIVERSITY OF PISA (IT)

WP3-4 Leader.

Responsibility: in vitro and in vivo validation of the I-GENE technology

WEBSITE

prochimia

PROCHIMIA SURFACES SP.Z.O.O. (PL)  

WP2 Leader/SME.

Responsibility: Nanotransducer (NT) synthesis and characterization as well as standardization of the reagents and the kit for future commercialization of the I-GENE technology (in the field of nano-coupled molecular biology)

WEBSITE

iit

ISTITUTO ITALIANO DI TECNOLOGIA (IT)/ Plasmon Nanotechnologies line

WP1 Leader.

Responsibility: in silico simulations; optimization of the structure, composition and the functionality of the Nanoparticles (NPs) in association with the properties of the laser

WEBSITE

msquared

M-SQAURED LASERS LIMITED (UK)

WP5 co-Leader/SME.

 Responsibility: safety control of the laser beam irradiation and development of a laser probe specifically designed for the photoactivation of the NTs in vivo

WEBSITE

lionix

LIONIX INTERNATIONAL BV (NL)

WP5 co-Leader/ SME.

Responsibility: development of ready-to-use lab-on-chip allowing effective genome editing by I-GENE technology for biotechnological applications

WEBSITE

The Consortium

4

EUROPEAN COUNTRIES

2

ACADEMIES

3

SMEs